Generex signs Worldwide Licensing Deal $2.5 million upfront for the Ii-Key-H1 vaccine from NuGenerex-Immuno-Oncology (NGIO)...

Generex Inks $50 Million $50 million licensing deal for the Ii-Key platform to develop vaccines...

Generex Biotechnology Update on the Ii-Key COVID Vaccine Livestream Interview on Friday November 13 at...

In Case You Missed It – Mr. Hartman discusses recent accomplishments and new opportunities. JACKSON...